Unusual Symptoms

Lab Test Results October 23, 2012


CBC With Differential/Platelet
Test In Range Out Of Range Units Reference
WBC 4.1   x10E3/uL 4.0 - 10.5
RBC 4.42   x10E6/uL 4.14 - 5.80
Hemoglobin 14.1   g/dL 12.6 - 17.7
Hematocrit 42.2   % 37.5 - 51.0
MCV 96   fL 79 - 97
MCH 31.9   pg 26.6 - 33.0
MCHC 33.4   g/dL 31.5 - 35.7
RDW 13.5   % 12.3 - 15.4
Platelets 243   x10E3/uL 140 - 415
Neutorophils 58   % 40 - 74
Lymphs 26   % 14 - 46
Monocytes 12   % 4 - 13
Eos 3   % 0 - 7
Basos 1   % 0 - 3
Neutrophils (Absolute) 2.4   x10E3/uL 1.8 - 7.8
Lymphs (Absolute) 1.1   x10E3/uL 0.7 - 4.5
Monocytes (Absolute) 0.5   x10E3/uL 0.1 - 1.0
Eos (Absolute) 0.1   x10E3/uL 0.0 - 0.4
Baso (Absolute) 0.0   x10E3/uL 0.0 - 0.2
Immature Granulocytes 0   % 0 - 2
Immature Grans (Abs) 0.0   x10E3/uL 0.0 - 0.1
 

Comp. Metabolic Panel
Test In Range Out Of Range Units Reference
Glucose, Serum   103 H mg/dL 65 - 99
BUN 22   mg/dL 8 - 27
Creatinine, Serum   1.28 H mg/dL 0.26 - 1.27
wGFR If NonAfricn Am   L 56 mL/min/1.73 > 59
wGFR If Africn Am 65   mL/min/1.73 > 59
BUN/Creatinine Ratio 17   Ratio 10 - 22
Sodium, Serum 143   mmoL/L 134 - 144
Potassium, Serum 5.1   mmoL/L 3.5 - 5.2
Chloride, Serum 104   mmoL/L 97 - 108
Carbon Dioxide, Total 27   mmoL/L 20 - 32
Calcium, Serum 9.9   mg/dL 8.6 - 10.2
Protein, Total, Serum 7.0   g/dL 6.0 - 8.5
Albumin, Serum 4.7   g/dL 3.5 - 4.8
Globulin, Total 2.3   g/dL 1.5 - 4.5
A/G Ratio 2.0   Ratio 1.1 - 2.5
Bilirubin, Total 0.5   mg/dL 0.0 - 1.2
Alkaline Phosphatase, Serum 54   IU/L 25 - 160
AST (SGOT) 18   IU/L 0 - 40
ALT (SGPT) 15   IU/L 0 - 55
  **Effective October 29, 2012 the reference interval for ALT (SGPT) will be changing to:
 
  Male Female
0 - 11 years 0 - 29 0 - 28
12 - 17 years 0 - 30 0 - 24
> 17 years 0 - 44 0 - 32

Lipid Profile
Test In Range Out Of Range Units Reference
Cholesterol, Total   202 mg/dL 100 - 199
Triglyceride 80   mg/dL 0 - 149
HDL Cholesterol 97   mg/dL > 39
According to ATP-III Guidelines, HDL-C > 59 mg/dL is considered a negative risk factor for CHD.
LDL Cholesterol (calculated) 89   mg/dL 0 - 99
VLDL Cholesterol Cal 16   mg/dL 5 - 40

PSA, Total + %Free
Prostate Specific Ag, Serum   5.3 H ng/mL 0 - 4.0
Roche ECLIA methodology
According to the American Urological Association, Serum PSA should decrease and remain at undtecable levels after radicalprostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater.

Values obtained with different assay methods or kits cannot bew used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.
 
PSA, Free 1.19   ng/mL N/A
  Roche ECLIA methodology
%Free PSA 22.5   %  
The table below lists the probablility of prostate canceer for men with non-suspicious DRE results and total PSA between 4 and 10 ng.mL by patient age (Catalone et al, JAMA 1998,279:1542).
%Free PSA 50 - 64 yr 65 - 75 yr
0.00 - 10.00% 56% 55%
10.01 - 15.00 24% 35%
15.01 - 20.00 17% 23%
20.01 - 25% 10% 20%
> 25.00% 5% 9%
Please note: Catalona et al did not make specific recommendations regarding the use of percent free PSA for any other population of men.
 
Hemoglobin Alc   5.7 H % 4.8 - 5.6
  Increased risk for diabetes: 5.7 - 6.4
Diabetes: > 6.4
Glycemic control for adults with diabetes: < 7.0
 
Vitamin D, 25-Hydroxy 52.8   ng/mL 30 - 100.0
Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-OH vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/mL (2).
1. IOM (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30.
 
Antinucleart Antibodies Direct negative     negative
Sedimentation Rate-Westergren 2   mm/hr 0 - 30
Vitamin B12 787   pg/mL 211 - 946
Magnesium, Serum 2.4   mg/dL 1.6 - 2.6
Zinc, Plasma or Serum 100   ug/dL 56 - 134
  **Please note reference interval change.**
Ferritin, Serum 51   ng/mL 30 - 400
Lead, Blood (Adult) > 2   ug/dL 0 - 19
The Centers for Disease Control and Prevention states blood lead levels less than 10 ug/dL in childrenhave been associated with numerous adverse health effects. New York State Guidliines: Blood lead levels in the range 5 - 9 ug/dL have been associated with adverse health effects in children aged 6 year and younger
Environmental Exposure: WHO Recommendation: < 20
Occupational Exposure: OSHA Lead Std: 40
 
  Detection Limit = 1